Literature DB >> 31206609

Neutrophil extracellular trap-microparticle complexes trigger neutrophil recruitment via high-mobility group protein 1 (HMGB1)-toll-like receptors(TLR2)/TLR4 signalling.

Yongzhi Wang1, Feifei Du1, Avin Hawez1, Matthias Mörgelin2, Henrik Thorlacius1.   

Abstract

BACKGROUND AND
PURPOSE: Recent data suggest that neutrophil extracellular traps (NETs) form aggregates with microparticles (MPs) upon activation of neutrophils although the functional role of NET-MP complexes remain elusive. The objective of this study was to examine the role of NET-MP aggregates in leukocyte recruitment in vivo. EXPERIMENTAL APPROACH: PMA stimulation of murine bone marrow neutrophils generated NET-MP complexes and pretreatment with caspase and calpain inhibitors resulted in the formation of NETs depleted of MPs. Leukocyte-endothelium interactions were studied by using intravital microscopy of the mouse cremaster microcirculation. KEY
RESULTS: Intrascrotal injection of NET-MP aggregates dose-dependently increased leukocyte recruitment. In contrast, leukocyte responses were markedly reduced after administration of NETs depleted of MPs. Neutrophil depletion abolished intravascular and extravascular leukocytes in response to challenge with NET-MP complexes. Electron microscopy revealed that NET-associated MPs express HMGB1. Notably, immunoneutralization of HMGB1 markedly decreased NET-MP complex-induced neutrophil accumulation. Moreover, inhibition of TLR2 and TLR4 significantly reduced neutrophil recruitment in response to NET-MP aggregates. CONCLUSIONS AND IMPLICATIONS: These data show that NET-MP complexes are potent inducers of neutrophil recruitment, which is dependent on HMGB1 expressed on MPs and mediated via TLR2 and TLR4. Blocking MP binding to NETs or downstream inhibition of the HMGB1-TLR2/TLR4 axis might provide useful targets to attenuating NET-dependent tissue damage in acute inflammation.
© 2019 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31206609      PMCID: PMC6692579          DOI: 10.1111/bph.14765

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  61 in total

1.  Cytokine-induced leukocyte rolling in mouse cremaster muscle arterioles in P-selectin dependent.

Authors:  H Thorlacius; L Lindbom; J Raud
Journal:  Am J Physiol       Date:  1997-04

Review 2.  Role of high-mobility group box-1 protein in disruption of vascular barriers and regulation of leukocyte-endothelial interactions.

Authors:  Mohd Imtiaz Nawaz; Ghulam Mohammad
Journal:  J Recept Signal Transduct Res       Date:  2014-11-19       Impact factor: 2.092

3.  CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms.

Authors:  A C Issekutz; H E Chuluyan; N Lopes
Journal:  J Leukoc Biol       Date:  1995-04       Impact factor: 4.962

4.  The in vivo and in vitro effects of antibodies against rabbit beta 2-integrins.

Authors:  J Rutter; T J James; D Howat; A Shock; D Andrew; P De Baetselier; J Blackford; J M Wilkinson; G Higgs; B Hughes
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

5.  Fundamental and distinct roles of P-selectin and LFA-1 in ischemia/reperfusion-induced leukocyte-endothelium interactions in the mouse colon.

Authors:  Amjid Ali Riaz; Ming Xiu Wan; Thilo Schaefer; Rene Schramm; Henrik Ekberg; Michael D Menger; Bengt Jeppsson; Henrik Thorlacius
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

6.  An approach for studies of mediator-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery.

Authors:  K Yamaki; L Lindbom; H Thorlacius; P Hedqvist; J Raud
Journal:  Br J Pharmacol       Date:  1998-02       Impact factor: 8.739

7.  Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses.

Authors:  Ian Sabroe; Elizabeth C Jones; Lynne R Usher; Moira K B Whyte; Steven K Dower
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo.

Authors:  K E Arfors; C Lundberg; L Lindbom; K Lundberg; P G Beatty; J M Harlan
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

9.  Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease.

Authors:  Zhangxiu He; Yu Si; Tao Jiang; Ruishuang Ma; Yan Zhang; Muhua Cao; Tao Li; Zhipeng Yao; Lu Zhao; Shaohong Fang; Bo Yu; Zengxiang Dong; Hemant S Thatte; Yayan Bi; Junjie Kou; Shufen Yang; Daxun Piao; Lirong Hao; Jin Zhou; Jialan Shi
Journal:  Thromb Haemost       Date:  2015-12-10       Impact factor: 5.249

10.  The alpha 4-integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo.

Authors:  B Johnston; T B Issekutz; P Kubes
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  19 in total

1.  Neutrophil extracellular trap-microparticle complexes trigger neutrophil recruitment via high-mobility group protein 1 (HMGB1)-toll-like receptors(TLR2)/TLR4 signalling.

Authors:  Yongzhi Wang; Feifei Du; Avin Hawez; Matthias Mörgelin; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2019-06-17       Impact factor: 8.739

2.  Extracellular cold-inducible RNA-binding protein regulates neutrophil extracellular trap formation and tissue damage in acute pancreatitis.

Authors:  Johan Linders; Raed Madhi; Milladur Rahman; Matthias Mörgelin; Sara Regner; Max Brenner; Ping Wang; Henrik Thorlacius
Journal:  Lab Invest       Date:  2020-07-24       Impact factor: 5.662

Review 3.  Nets, pulmonary arterial hypertension, and thrombo-inflammation.

Authors:  Luís Pedro Baptista de Barros Ribeiro Dourado; Mário Santos; Daniel Moreira-Gonçalves
Journal:  J Mol Med (Berl)       Date:  2022-04-20       Impact factor: 4.599

Review 4.  Neutrophil Extracellular Traps Exacerbate Ischemic Brain Damage.

Authors:  Congqin Li; Ying Xing; Yuqian Zhang; Yan Hua; Jian Hu; Yulong Bai
Journal:  Mol Neurobiol       Date:  2021-11-08       Impact factor: 5.590

Review 5.  Tumor regionalization after surgery: Roles of the tumor microenvironment and neutrophil extracellular traps.

Authors:  Su-Bin Kwak; Sang Jin Kim; Jiyoung Kim; Ye-Lim Kang; Chang Woo Ko; Iljin Kim; Jong-Wan Park
Journal:  Exp Mol Med       Date:  2022-06-28       Impact factor: 12.153

Review 6.  The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

7.  Toll-like Receptor 4 Deficiency Aggravates Airway Hyperresponsiveness and Inflammation by Impairing Neutrophil Apoptosis in a Toluene Diisocyanate-Induced Murine Asthma Model.

Authors:  Shuyu Chen; Yao Deng; Qiaoling He; Yanbo Chen; Weimin Sun; Ying He; Zehong Zou; Zhenyu Liang; Rongchang Chen; Lihong Yao; Ailin Tao
Journal:  Allergy Asthma Immunol Res       Date:  2020-07       Impact factor: 5.764

8.  Identification of the key differentially expressed genes and pathways involved in neutrophilia.

Authors:  Chengcheng He; Yingchun Zhang; Hongwei Luo; Bo Luo; Yancheng He; Nan Jiang; Yu Liang; Jingyuan Zeng; Yujiao Luo; Yujun Xian; Jiajia Liu; Xiaoli Zheng
Journal:  Innate Immun       Date:  2019-11-15       Impact factor: 2.680

9.  Pre-treatment with compound Danshen dripping pills prevents lipid infusion-induced microvascular dysfunction in mice.

Authors:  Yanda Zhang; Jian Zhao; Ru Ding; Wenhao Niu; Zhiqing He; Chun Liang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

Review 10.  COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review).

Authors:  Shuoqi Zhang; Jinming Zhang; Chunxu Wang; Xiaojing Chen; Xinyi Zhao; Haijiao Jing; Huan Liu; Zhuxin Li; Lihua Wang; Jialan Shi
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.